REGEnLIFE
PrivateLast Round
Series A
May 9, 2023
Total Funding Raised
$6.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
REGEnLIFE is a therapeutic devices company that develops a non-invasive medical device designed to alter the progression of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
REGEnLIFE Comparables
Compare REGEnLIFE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroEM Therapeutics | 81% | |
| Neurocia SAS | 80% | |
| Cognito Therapeutics | 79% |
REGEnLIFE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 9, 2023 | ||||
| Seed | Jul 10, 2019 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 50% MoM.
- Jun 17, 2026
Monthly visitors increased 52% MoM.
Recent news
Latest coverage and updates
- hiresAug 22, 2026
REGEnLIFE hired Volker Herrmann as Chief Executive Officer on Jul 15th '26.
- expands_facilitiesAug 22, 2026
REGEnLIFE expands facilities to Nantes, France, Western Europe, Europe.
REGEnLIFE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about REGEnLIFE's valuation, stock price, and market status.
Is REGEnLIFE a public or private company?
REGEnLIFE is a private company.
What is the current stock price of REGEnLIFE?
REGEnLIFE is a private company with no public stock price. No recent secondary market data is available.
How much is REGEnLIFE worth (valuation)?
Valuation information for REGEnLIFE is not publicly available.
Can I buy REGEnLIFE stock?
REGEnLIFE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was REGEnLIFE's last funding round?
REGEnLIFE's most recent funding round was Series A on May 9, 2023.
Who are the main investors in REGEnLIFE?
Investor information for REGEnLIFE is not publicly disclosed.
Will REGEnLIFE IPO soon?
No public IPO plans have been announced for REGEnLIFE.
How can I track REGEnLIFE secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor REGEnLIFE's secondary market activity and sign up for updates.